The Role of Cytokines in Health and Disease
Deadline for manuscript submissions: closed (31 August 2023) | Viewed by 14614
Interests: neurodegenerative diseases; cancer; specific proteins; cytokines; biomarkers; non-invasive diagnosis
Special Issues, Collections and Topics in MDPI journals
The subject of this Special Issue mainly covers the usefulness of the determination of cytokines in healthy patients and patients with civilization diseases, with particular emphasis on neurodegenerative and neoplastic diseases. Despite being non-contagious, civilization diseases are often referred to as the epidemics of the 21st century because they spread globally and lead to over 80% of premature deaths. For many years, it has been observed that society is progressively ageing, which results in an increase in the number of elderly people who are most at risk of developing degenerative diseases of the central nervous system, as well as cancer. As part of this Special Issue, we are looking for new indicators allowing for early detection (even in potentially healthy patients, years before first symptoms of the emerging disease), and thus a better prognosis of survival of patients with selected civilization diseases. It is assumed that the introduction of the concentrations of the analyzed proteins to the diagnosis of patients with civilization diseases may facilitate the diagnosis and differentiation of these diseases, and thus enable early initiation of treatment.
This Special Issue aims to comprehensively study the role of cytokines in health and in various diseases (mainly, but not only, diseases of civilization, such as cancers or neurodegenerative diseases). Moreover, the aim of this Special Issue is also to understand the involvement of different cytokine groups in diagnosis and/or therapy and to investigate new potential therapies targeting cytokines. In this Special Issue, original research articles and reviews are welcome.
Research areas may include (but are not limited to) the following:
- Cytokines as prognostic factors of different diseases;
- Cytokines as novel tumor markers in malignant tumors;
- Cytokines in neurodegeneration;
- Cytokines in neuroinflammation;
- Cytokines in COVID-19;
- Potential novel role of cytokines in health and disease.
I look forward to receiving your contributions.
Dr. Monika Zajkowska
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- neurodegenerative disease
- inflammatory mediator